MGNX
Macrogenics Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.
$ 3.21
6.42 %
Macrogenics Inc
$
3.21
6.42 %
MGNX
MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.
Price history of Macrogenics Inc
Price history of Macrogenics Inc
Performance & Momentum
6 Months
75.14 %
1 Year
87.43 %
3 Years
52.16 %
5 Years
90.79 %
Similar stocks to Macrogenics Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
